<DOC>
	<DOCNO>NCT01435317</DOCNO>
	<brief_summary>Confirmation efficacy safety acoustic CR®-neuromodulation treatment chronic tinnitus patient use CE mark ANM T30 CR®-system real life outpatient set . - Identification early indicator therapy success - Comparison different patient group regard : tinnitus severity , tinnitus duration , level hearing loss , stimulation pattern , unilateral monotonal vs. complex form - Representative set safety data broad patient spectrum - Measurement tinnitus burden ( TBF-12 Questionnaire ) - Generation longterm compliance data</brief_summary>
	<brief_title>Acoustic Coordinated Reset ( CR® ) Neuromodulation Treatment Chronic Tonal Tinnitus ( `` RESET Real Life '' )</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<criteria>Main symptomatic subjective tonal chronical ( &gt; 3 month ) tinnitus &lt; 60dB hearing loss men woman ≥18 year old Main serious neurologic psychiatric internistic disease objective tinnitus Morbus Menière craniomandibular trigger tinnitus</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Acoustic CR®-neuromodulation</keyword>
	<keyword>ANM T30 CR®-System</keyword>
</DOC>